Seiichi Mori
Seiichi Mori
Genome Center, Japanese Foundation for Cancer Research
Verified email at jfcr.or.jp
Title
Cited by
Cited by
Year
Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2
Y Yokota, A Mansouri, S Mori, S Sugawara, S Adachi, SI Nishikawa, ...
Nature 397 (6721), 702-706, 1999
9471999
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
T Baba, PA Convery, N Matsumura, RS Whitaker, E Kondoh, T Perry, ...
Oncogene 28 (2), 209-218, 2009
4632009
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
TZ Tan, QH Miow, Y Miki, T Noda, S Mori, RYJ Huang, JP Thiery
EMBO molecular medicine 6 (10), 1279-1293, 2014
4212014
A bistable Rb–E2F switch underlies the restriction point
G Yao, TJ Lee, S Mori, JR Nevins, L You
Nature cell biology 10 (4), 476-482, 2008
4012008
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor …
RYJ Huang, MK Wong, TZ Tan, KT Kuay, AHC Ng, VY Chung, YS Chu, ...
Cell death & disease 4 (11), e915-e915, 2013
2982013
Role of Id family proteins in growth control
Y Yokota, S Mori
Journal of cellular physiology 190 (1), 21-28, 2002
2922002
Anchorage-independent cell growth signature identifies tumors with metastatic potential
S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ...
Oncogene 28 (31), 2796-2805, 2009
2852009
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
TC Hallstrom, S Mori, JR Nevins
Cancer cell 13 (1), 11-22, 2008
2592008
The genomic analysis of lactic acidosis and acidosis response in human cancers
JLY Chen, JE Lucas, T Schroeder, S Mori, J Wu, J Nevins, M Dewhirst, ...
PLoS Genet 4 (12), e1000293, 2008
1882008
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ...
EMBO molecular medicine 5 (7), 1051-1066, 2013
1562013
Lactation defect in mice lacking the helix–loop–helix inhibitor Id2
S Mori, SI Nishikawa, Y Yokota
The EMBO journal 19 (21), 5772-5781, 2000
1552000
A genomic strategy to elucidate modules of oncogenic pathway signaling networks
JT Chang, C Carvalho, S Mori, AH Bild, ML Gatza, Q Wang, JE Lucas, ...
Molecular cell 34 (1), 104-114, 2009
1332009
Using a stem cell–based signature to guide therapeutic selection in cancer
I Shats, ML Gatza, JT Chang, S Mori, J Wang, J Rich, JR Nevins
Cancer research 71 (5), 1772-1780, 2011
1142011
SIRT2 down‐regulation in HeLa can induce p53 accumulation via p38 MAPK activation‐dependent p300 decrease, eventually leading to apoptosis
Y Li, H Matsumori, Y Nakayama, M Osaki, H Kojima, A Kurimasa, H Ito, ...
Genes to Cells 16 (1), 34-45, 2011
1142011
A role for E2F6 in distinguishing G1/S-and G2/M-specific transcription
PH Giangrande, W Zhu, S Schlisio, X Sun, S Mori, S Gaubatz, JR Nevins
Genes & development 18 (23), 2941-2951, 2004
1112004
A novel snail-related transcription factor Smuc regulates basic helix–loop–helix transcription factor activities via specific E-box motifs
H Kataoka, T Murayama, M Yokode, S Mori, H Sano, H Ozaki, Y Yokota, ...
Nucleic acids research 28 (2), 626-633, 2000
1102000
FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway
M Asad, MK Wong, TZ Tan, M Choolani, J Low, S Mori, D Virshup, ...
Cell death & disease 5 (7), e1346-e1346, 2014
1042014
Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
QH Miow, TZ Tan, J Ye, JA Lau, T Yokomizo, JP Thiery, S Mori
Oncogene 34 (15), 1899-1907, 2015
1002015
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer
N Matsumura, Z Huang, S Mori, T Baba, S Fujii, I Konishi, ES Iversen, ...
Genome research 21 (1), 74-82, 2011
972011
Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects
CQ Wang, V Krishnan, LS Tay, DWL Chin, CP Koh, JY Chooi, GSS Nah, ...
Cell reports 8 (3), 767-782, 2014
812014
The system can't perform the operation now. Try again later.
Articles 1–20